Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors-Reference-Cited by-同舟云学术

Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors

Published:2016-03-09 Issue:15 Volume:7 Page:20753-20772
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kopecka Joanna¹,Porto Stefania²,Lusa Sara³,Gazzano Elena¹,Salzano Giuseppina⁴,Pinzòn-Daza Martha Leonor¹⁵,Giordano Antonio⁶,Desiderio Vincenzo⁷,Ghigo Dario¹,De Rosa Giuseppe³,Caraglia Michele²⁶,Riganti Chiara¹

Affiliation:

1. Department of Oncology, University of Turin, Turin, Italy

2. Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy

3. Department of Pharmacy, Federico II University of Naples, Naples, Italy

4. Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA

5. Universidad del Rosario, Facultad de Ciencias Naturales y Matemáticas, RG in Biochemistry and Biotechnology (BIO-BIO), Bogotá, Colombia

6. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA

7. Department of Experimental Medicine, Second University of Naples, Naples, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer;Journal of Experimental & Clinical Cancer Research;2024-08-07

2. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches;Acta Pharmaceutica Sinica B;2024-06

3. Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma;Anticancer Research;2024-05-31

4. Unraveling the Dual Inhibitory Mechanism of Compound 22ac: A Molecular Dynamics Investigation into ERK1 and ERK5 Inhibition in Cancer;Computation;2024-03-01

5. Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress;Pharmaceutics;2024-02-08